Transtympanic management of tinnitus

Otolaryngologic Clinics of North America

Volumn 36, Issue 2, 2003, Pages 353-358

  Hoffer, Michael E ^a   Wester, Derin ^a   Kopke, Richard D ^a   Weisskopf, Peter ^a   Gottshall, Kim ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIOXIDANT; GENTAMICIN; LIDOCAINE; METHYLPREDNISOLONE; STEROID;

ARTICLE; DRUG DELIVERY SYSTEM; EARDRUM; HEARING LOSS; HUMAN; IDIOPATHIC DISEASE; MENIERE DISEASE; PERCEPTION DEAFNESS; TINNITUS; TREATMENT INDICATION;

EID: 0038068923     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6665(02)00166-4     Document Type: Article

References (18)

1. Shulman A. Noise, calpain, calpain inhibitors, and neuroprotection: a preliminary report in tinnitus control. Int Tinnitus J 1998;4:134-40.
2. DeCicco MJ, Hoffer ME, Kopke RD, et al. Round-window microcatheter-administered gentamicin: results from treatment of tinnitus associated with Meniere's disease. Int Tinnitus J 1998;4:141-3.
3. Dehler R, Dehler F, Claussen CF, et al. Competitive-kinesthetic interaction therapy. Int Tinnitus J 2000;6:29-36.
4. Gul H, Nowak R, Buchner FA, et al. Different treatment modalities of tinnitus at the Euromed Clinic. Int Tinnitus J 2000;6:50-3.
5. Seidman MD. Glutamate antagonists, steroids, and antioxidants as therapeutic options for hearing loss and tinnitus and the use of an inner ear delivery system. Int Tinnitus J 1998;4:148-54.
6. Schuknecht H. Ablation therapy in Meniere's disease. Acta Otolaryngol Suppl (Stockh) 1957;132:1-42.
7. Beck C, Schmidt CL. 10 years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of Morbus Meniere. Arch Otorhinolaryngol 1978;221:149-52.
8. Blakley BW. Clinical forum: a review of intratympanic therapy. Am J Otol 1997;18:5206.
9. Kaplan DM, Nedzelski JM, Chen JM, et al. Intratympanic gentamicin for the treatment of unilateral Meniere's Disease. Laryngoscope 2000;1100:1298-305.
10. Odkvist LM. Middle ear ototoxic treatment for inner ear disease. Acta Otolaryngol Suppl 1989;457:83-6.
11. Hoffer ME, Kopke RD, Weisskopf P, et al. Use of the round window microcatheter in the treatment of Meniere's disease. Laryngoscope 2001;111:2046-9.
12. Monsell EM, Balkany TA, Gates GA, Goldenberg RA, Meyerhoff WL, House JW. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 1995;113:181-5.
13. Driscoll CL, Kasperbauer JL, Facer GW, et al. Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results. Laryngoscope 1997;107:83-9.
14. Minor LB. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Am J Otol 1999;20:209-19.
15. Silverstein H, Arruda J, Rosenberg SI, et al. Direct round window membrane application of gentamicin in the treatment of Meniere's disease. Otolaryngol Head Neck Surg 1999; 120:649-55.
16. Sakata E, Itoh A, Itoh Y. Treatment of cochlear tinnitus with dexamethasone infusion into the tympanic cavity. Int Tinnitus J 1996;2:129-35.
17. Shulman A, Goldstein B. Intratympanic drug therapy with steroids for tinnitus control: a preliminary report. Int Tinnitus J 2000;6:10-21.
18. Kopke RD, Hoffer ME, Wester D, et al. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otology and Neurotology 2001;22:475-9.